This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData support further development of BT-001 in solid tumors ...
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData support further development of BT-001 in solid tumors ...
In recognition of his contributions to viral vector–based therapeutics and translation, Dr. Curiel was elected a Fellow of the National Academy of Inventors. He is also a co-founder of biotech ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback